New epigenetic biomarkers found that potentially predict preterm birth

Immunotherapy drug bolsters head and neck cancer treatment
1 March 2022
Gender-affirming hormone therapy can influence gene activity
1 March 2022

New epigenetic biomarkers found that potentially predict preterm birth

A signature found in the cheek cells of mothers and fathers of preterm infants may help develop a test to determine whether a pregnancy may end too early. Such a test could help prevent premature births and the many resulting health impacts on infants by alerting medical providers to the need for early intervention measures.

Comments are closed.